GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pharma Aids Ltd (DHA:PHARMAID) » Definitions » Equity-to-Asset

Pharma Aids (DHA:PHARMAID) Equity-to-Asset : 0.72 (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Pharma Aids Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Pharma Aids's Total Stockholders Equity for the quarter that ended in Mar. 2025 was BDT417.8 Mil. Pharma Aids's Total Assets for the quarter that ended in Mar. 2025 was BDT583.2 Mil. Therefore, Pharma Aids's Equity to Asset Ratio for the quarter that ended in Mar. 2025 was 0.72.

The historical rank and industry rank for Pharma Aids's Equity-to-Asset or its related term are showing as below:

DHA:PHARMAID' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.53   Med: 0.74   Max: 0.9
Current: 0.72

During the past 13 years, the highest Equity to Asset Ratio of Pharma Aids was 0.90. The lowest was 0.53. And the median was 0.74.

DHA:PHARMAID's Equity-to-Asset is ranked better than
57.72% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: 0.63 vs DHA:PHARMAID: 0.72

Pharma Aids Equity-to-Asset Historical Data

The historical data trend for Pharma Aids's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Aids Equity-to-Asset Chart

Pharma Aids Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 0.85 0.81 0.75 0.71

Pharma Aids Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.74 0.71 0.71 0.69 0.72

Competitive Comparison of Pharma Aids's Equity-to-Asset

For the Medical Instruments & Supplies subindustry, Pharma Aids's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Aids's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pharma Aids's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Pharma Aids's Equity-to-Asset falls into.


;
;

Pharma Aids Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Pharma Aids's Equity to Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Equity to Asset (A: Jun. 2024 )=Total Stockholders Equity/Total Assets
=342.845/480.192
=0.71

Pharma Aids's Equity to Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

Equity to Asset (Q: Mar. 2025 )=Total Stockholders Equity/Total Assets
=417.849/583.215
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharma Aids  (DHA:PHARMAID) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Pharma Aids Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Pharma Aids's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Aids Business Description

Traded in Other Exchanges
N/A
Address
345 Segun Bagicha, 1st Floor, Ramna, Dhaka, BGD, 1000
Pharma Aids Ltd is a Bangladesh-based company engaged in the manufacturing of neutral glass ampoules, USP Type-I. Ampoules are used by pharmaceutical companies for filling liquid injections. The company produces different sizes of ampoules from 1ml to 25ml, in Clear and Amber color, and in Amber color, and of both Open Mouth (Form B and C) and Close Mouth (Form D, Din and Marzocchi type).

Pharma Aids Headlines

No Headlines